Text Size

Prostatectomy Prospective DataBase

This study is ongoing, but not recruiting participants.
Sponsor:
Information provided by (Responsible Party):
Kenneth Peters, MD, William Beaumont Hospitals
ClinicalTrials.gov Identifier:
NCT00447616
First received: March 13, 2007
Last updated: November 9, 2012
Last verified: November 2012
History of Changes
  Purpose

The purpose of establishing the database is to evaluate the effects of surgical removal of the prostate (prostatectomy) and cryosurgery on prostate cancer, quality of life, and overall health.


Condition
Prostate Cancer

Study Type: Observational
Study Design: Time Perspective: Prospective
Official Title: Prostatectomy DataBase

Resource links provided by NLM:

U.S. FDA Resources

Further study details as provided by William Beaumont Hospitals:

Enrollment: 896
Study Start Date: October 2003
Estimated Study Completion Date: October 2029
Detailed Description:

The purpose of establishing the database is to evaluate the effects of surgical removal of the prostate (prostatectomy) and cryosurgery on prostate cancer, quality of life, and overall health. Participation in the study will allow collection of medical information related to prostate cancer treatment from hospital and doctor's office records. Questionnaires will be completed reflecting bladder, bowel, and sexual function, and quality of life at three, six, twelve, eighteen, and twenty-four months after surgery, and yearly thereafter.

  Eligibility

Ages Eligible for Study:   18 Years and older
Genders Eligible for Study:   Male
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population

Patients having prostatectomy or cryosurgery for the treatment of prostate cancer at William Beaumont Hospital.

Criteria

Inclusion Criteria:

  • males greater than 18 years of age
  • patients having prostatectomy or cryosurgery for the treatment of prostate cancer at William Beaumont Hospital.

Exclusion Criteria:

  • dementia
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT00447616

Locations
United States, Michigan
William Beaumont Hospital
Royal Oak, Michigan, United States, 48073
Sponsors and Collaborators
Kenneth Peters, MD
Investigators
Principal Investigator: Kenneth M Peters, M.D. William Beaumont Hospitals
  More Information

No publications provided

Responsible Party: Kenneth Peters, MD, Principal Investigator, William Beaumont Hospitals
ClinicalTrials.gov Identifier: NCT00447616     History of Changes
Other Study ID Numbers: 2003-214
Study First Received: March 13, 2007
Last Updated: November 9, 2012
Health Authority: United States: Institutional Review Board

Keywords provided by William Beaumont Hospitals:
Prostate Cancer
Prostatectomy

Additional relevant MeSH terms:
Prostatic Neoplasms
Genital Neoplasms, Male
Urogenital Neoplasms
Neoplasms by Site
 Neoplasms
Genital Diseases, Male
Prostatic Diseases

ClinicalTrials.gov processed this record on May 21, 2013